Institute for Global Health



A prospective observational cohort study of HIV-positive individuals in Europe, Israel and Argentina

Project Summary 

EuroSIDA is a prospective observational cohort study that was initiated in 1994 to follow the long-term clinical prognosis for the general population of HIV-infected individuals in Europe and to assess the impact of antiretroviral drug treatment on their long-term prognosis.

To date almost 23000 individuals have been followed in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. EuroSIDA aims to study the long-term virological, immunological and clinical outcomes and to monitor temporal changes and regional differences across Europe.  EuroSIDA has investigated co-infection with Hepatitis C virus and clinical events including liver, renal and cardiovascular disease and non-AIDS defining cancers.

EuroSIDA was one of the cohorts to found The International Cohort Consortium of Infectious Disease (RESPOND) cohort consortium on infectious diseases in 2017.

Links to other research

Other research from the UCL Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME)

Other research from IGH on Cohort Studies, HIV, Hepatitis and Treatment

Other research from IGH in Europe, Israel and Argentina